Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
This is a 40% decrease from the number of companies inspected in the previous quarter, when five companies received five inspections.
Most of the companies inspected at the time were involved in the Devices sector. The Biologics and Drugs sectors sectors, along with two other sectors, tied for second most common type.
There were two companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct its management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Bio Med Sciences, Inc. | Devices | 03/21/2024 | Voluntary Action Indicated (VAI) |
| Lehigh Valley Health Network IRB | Biologics | 02/09/2024 | No Action Indicated (NAI) |
| Lehigh Valley Health Network IRB | Devices | 02/09/2024 | No Action Indicated (NAI) |
| Lehigh Valley Health Network IRB | Drugs | 02/09/2024 | No Action Indicated (NAI) |
| Lineage Logistics, LLC | Food and Cosmetics | 03/06/2024 | No Action Indicated (NAI) |
| Lineage Logistics, LLC | Veterinary | 03/06/2024 | No Action Indicated (NAI) |
Alerts Sign-up